DiGeronimo was part of the ownership group that controlled the property sold to the Browns for the new stadium. And it is one ...

President Trump signed the Epstein Files Transparency Act into law, officially directing the Department of Justice (DOJ) to release all unclassified records and documents connected to the convicted ...

WASHINGTON, Nov 19 (Reuters) - The White House quietly lobbied senators to slow-walk a vote to force the release of investigative files on Jeffrey Epstein even as President Donald Trump publicly ...

President Donald Trump signed the Epstein Files Transparency Act into law Wednesday, one day after the Senate passed the legislation by unanimous consent, requiring the Department of Justice to ...

WASHINGTON — President Donald Trump signed a bill Wednesday to compel the Justice Department to release files related to Jeffrey Epstein, capping off a monthslong bipartisan push in Congress that ...

At least two women who say they are survivors of Epstein’s abuse were expected to attend Grijalva’s swearing-in ceremony Wednesday afternoon, sources with knowledge told CNN. The House effort to ...

The big picture: Today's world runs on digital documents, but companies and users face a maze of incompatible proprietary file formats. LibreOffice developers contend that only strictly open standards ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The future of a $2 billion ...

Five Star Development, the developer of the Ritz-Carlton Paradise Valley, has filed for Chapter 11 bankruptcy protection. The filing halts foreclosure proceedings initiated by the project's main ...

Microsoft-backed (NASDAQ:MSFT) OpenAI introduced a new way for users to interact with ChatGPT today with the launch of Apps SDK, which provides access to various apps within the ChatGPT dialogue ...

Pfizer PFE0.19%increase; green up pointing triangle has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets the New York drugmaker back into the burgeoning ...